L3VLUP
← Every manager
Free · no sign-up · Q2 2026

Which funds own BIO

Bio Rad Labs Inc in the Q2 2026 filings. At least 3 of the 91 current managers on file reported a position, worth $810m between them. It is among the largest positions of fewer than a fifth of the current managers on file. Buying and selling roughly cancelled this quarter, which is what a name looks like when the argument is still live.

Managers holding
3
at least, of 91 current
Combined value
$810m
as reported
Opened
1
new this quarter
Added to
1
already held
Trimmed or sold out
2
1 sold out entirely

Only each manager’s largest 200 positions are listed here, so a smaller holder may be missing.

Managers reporting a position

Largest first. Weight is the share of that manager’s whole reported book, which is the number worth quoting: $400m is a rounding error in one book and a defining bet in another.

ManagerValueWeightSharesChange on the quarterAction
First Eagle Investment Management LLC
Value · $60.8bn book
$765m1.3%2,606,219+$40m+3,447Added
Freestone Grove Partners LP
Multi-strategy · $15.6bn book
$41m0.3%140,113unchanged-7,492Trimmed
Caxton Associates LLP
Macro · $5.3bn book
$4.1m0.1%13,875opened13,875New

Sold out of this quarter

Valued at what the position was worth in the previous filing, because by this one it is gone.

Ownership through time

At least 7 of the 95 managers whose filings are on file listed BIO in Q2 2026, against 5 in Q2 2013. 1 manager fewer than in Q1 2026: 1 started a position; 1 listed it again; 1 sold out, by its own filing; 2 no longer listed it among the positions read, which can mean a holding below the listed range, a filing that reported no holdings, or a filing not yet made.

Each manager’s largest 500 positions a quarter are read, so a small holding in a very large book can be missing, and a manager is counted as leaving only where its own filing shows it.

Managers on file listing it
01122Q2 2013: 5Q3 2013: 4Q4 2013: 2Q1 2014: 314Q2 2014: 4Q3 2014: 5Q4 2014: 5Q1 2015: 815Q2 2015: 6Q3 2015: 7Q4 2015: 7Q1 2016: 616Q2 2016: 4Q3 2016: 4Q4 2016: 7Q1 2017: 917Q2 2017: 8Q3 2017: 4Q4 2017: 13Q1 2018: 1318Q2 2018: 15Q3 2018: 16Q4 2018: 16Q1 2019: 1519Q2 2019: 14Q3 2019: 16Q4 2019: 12Q1 2020: 1220Q2 2020: 19Q3 2020: 17Q4 2020: 13Q1 2021: 1521Q2 2021: 18Q3 2021: 16Q4 2021: 19Q1 2022: 2222Q2 2022: 15Q3 2022: 17Q4 2022: 16Q1 2023: 1123Q2 2023: 16Q3 2023: 15Q4 2023: 11Q1 2024: 724Q2 2024: 6Q3 2024: 9Q4 2024: 11Q1 2025: 1025Q2 2025: 8Q3 2025: 8Q4 2025: 9Q1 2026: 826Q2 2026: 7
  • Q2 2013: 5
  • Q3 2013: 4
  • Q4 2013: 2
  • Q1 2014: 3
  • Q2 2014: 4
  • Q3 2014: 5
  • Q4 2014: 5
  • Q1 2015: 8
  • Q2 2015: 6
  • Q3 2015: 7
  • Q4 2015: 7
  • Q1 2016: 6
  • Q2 2016: 4
  • Q3 2016: 4
  • Q4 2016: 7
  • Q1 2017: 9
  • Q2 2017: 8
  • Q3 2017: 4
  • Q4 2017: 13
  • Q1 2018: 13
  • Q2 2018: 15
  • Q3 2018: 16
  • Q4 2018: 16
  • Q1 2019: 15
  • Q2 2019: 14
  • Q3 2019: 16
  • Q4 2019: 12
  • Q1 2020: 12
  • Q2 2020: 19
  • Q3 2020: 17
  • Q4 2020: 13
  • Q1 2021: 15
  • Q2 2021: 18
  • Q3 2021: 16
  • Q4 2021: 19
  • Q1 2022: 22
  • Q2 2022: 15
  • Q3 2022: 17
  • Q4 2022: 16
  • Q1 2023: 11
  • Q2 2023: 16
  • Q3 2023: 15
  • Q4 2023: 11
  • Q1 2024: 7
  • Q2 2024: 6
  • Q3 2024: 9
  • Q4 2024: 11
  • Q1 2025: 10
  • Q2 2025: 8
  • Q3 2025: 8
  • Q4 2025: 9
  • Q1 2026: 8
  • Q2 2026: 7
Their combined reported value
$0$2bn$3bnQ2 2013: $24mQ3 2013: $22mQ4 2013: $13mQ1 2014: $34m14Q2 2014: $33mQ3 2014: $22mQ4 2014: $41mQ1 2015: $145m15Q2 2015: $170mQ3 2015: $201mQ4 2015: $186mQ1 2016: $182m16Q2 2016: $188mQ3 2016: $224mQ4 2016: $317mQ1 2017: $340m17Q2 2017: $298mQ3 2017: $294mQ4 2017: $478mQ1 2018: $524m18Q2 2018: $657mQ3 2018: $686mQ4 2018: $498mQ1 2019: $689m19Q2 2019: $614mQ3 2019: $801mQ4 2019: $585mQ1 2020: $695m20Q2 2020: $1.3bnQ3 2020: $1.7bnQ4 2020: $2.2bnQ1 2021: $2.2bn21Q2 2021: $2.7bnQ3 2021: $3.5bnQ4 2021: $3.3bnQ1 2022: $2.4bn22Q2 2022: $1.2bnQ3 2022: $857mQ4 2022: $782mQ1 2023: $833m23Q2 2023: $607mQ3 2023: $662mQ4 2023: $534mQ1 2024: $342m24Q2 2024: $409mQ3 2024: $708mQ4 2024: $649mQ1 2025: $612m25Q2 2025: $780mQ3 2025: $983mQ4 2025: $1.2bnQ1 2026: $1.2bn26Q2 2026: $1.1bn
  • Q2 2013: $24m
  • Q3 2013: $22m
  • Q4 2013: $13m
  • Q1 2014: $34m
  • Q2 2014: $33m
  • Q3 2014: $22m
  • Q4 2014: $41m
  • Q1 2015: $145m
  • Q2 2015: $170m
  • Q3 2015: $201m
  • Q4 2015: $186m
  • Q1 2016: $182m
  • Q2 2016: $188m
  • Q3 2016: $224m
  • Q4 2016: $317m
  • Q1 2017: $340m
  • Q2 2017: $298m
  • Q3 2017: $294m
  • Q4 2017: $478m
  • Q1 2018: $524m
  • Q2 2018: $657m
  • Q3 2018: $686m
  • Q4 2018: $498m
  • Q1 2019: $689m
  • Q2 2019: $614m
  • Q3 2019: $801m
  • Q4 2019: $585m
  • Q1 2020: $695m
  • Q2 2020: $1.3bn
  • Q3 2020: $1.7bn
  • Q4 2020: $2.2bn
  • Q1 2021: $2.2bn
  • Q2 2021: $2.7bn
  • Q3 2021: $3.5bn
  • Q4 2021: $3.3bn
  • Q1 2022: $2.4bn
  • Q2 2022: $1.2bn
  • Q3 2022: $857m
  • Q4 2022: $782m
  • Q1 2023: $833m
  • Q2 2023: $607m
  • Q3 2023: $662m
  • Q4 2023: $534m
  • Q1 2024: $342m
  • Q2 2024: $409m
  • Q3 2024: $708m
  • Q4 2024: $649m
  • Q1 2025: $612m
  • Q2 2025: $780m
  • Q3 2025: $983m
  • Q4 2025: $1.2bn
  • Q1 2026: $1.2bn
  • Q2 2026: $1.1bn

Between the quarter ends of Q1 2026 and Q2 2026. Each change in shares is valued at the Q2 2026 price, so the price’s own move is left out; a 13F shows the two quarter ends, not when in between anything was bought or sold.

Started in Q2 2026

Largest increases, by shares

Largest decreases, by shares

ManagerValue over timeFirst listedLargestQ2 2026
First Eagle Investment Management LLCQ2 2023$779m$765m
Capital World InvestorsQ1 2026$136m$136m
Capital Research Global InvestorsQ3 2025$150m$130m
Freestone Grove Partners LPQ4 2024$41m$41m
GAMCO Investors IncQ2 2013$21m$7.9m
Caxton Associates LLPQ2 2017$4.1m$4.1m
Brevan Howard Capital Management LPQ3 2024$5.3m$4.0m
Fidelity (FMR LLC)Q1 2020$1.5bnlast listed Q1 2022
AllianceBernstein LPQ4 2016$443mlast listed Q4 2023
Marshall Wace LLPQ2 2017$328mlast listed Q3 2023
Invesco LtdQ2 2020$327mlast listed Q1 2022
Acadian Asset Management LLCQ3 2014$315mlast listed Q1 2026
Millennium Management LLCQ1 2014$219mlast listed Q1 2025
AQR Capital Management LLCQ3 2018$172mlast listed Q2 2022
Schonfeld Strategic Advisors LLCQ1 2016$152mlast listed Q2 2023
Southeastern Asset Management IncQ2 2023$123mlast listed Q1 2026
MFS Investment ManagementQ3 2023$121mlast listed Q1 2026

What BIO is worth

Knowing who owns it is half the question. The other half is what it is worth against the companies it trades beside, which is the one an interviewer will follow up with.

Build the comp set around BIO →

How much of the picture this is

A Form 13F reports US-listed long equity and nothing else: no shorts, no bonds, no cash and no non-US listings. It arrives forty-five days after the quarter ends, so a manager who sold in July still shows the position in a filing published in August. This page reads the managers on file here rather than every filer in the market, and each manager’s largest positions rather than the whole table, so a small position in a very large book may not appear. Say “their last filing showed” rather than “they own”, and the distinction will do you credit.

What to do with a name the funds are buying

Knowing who owns something is the start of a pitch, not the pitch. The next questions are what it is worth and why they were buying.

Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More

The holdings, every quarter, and the week between

One email a week on what moved in the market and what it means for the people interviewing into it, with the 13F changes the quarter they are filed.

One email a week, free, and you can leave at any point.